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Hodgkin Lymphoma (HL) is character ized by a minori ty of Reed-
Sternberg (RS) cells and a majority of reactive infiltrating cells, a distinct
feature from other lymphoid mal ignancies. In general ,  RS cel ls are
considered to be derived from germinal center (GC) B cells. RS cells from
classical  HL (cHL) do not express BcR, due to ei ther destruct ive somatic
hypermutations or defective lg transcription machinery. RS cell precursors
are rescued from apoptosis by a transforming event. In a proportion of HL
cases, EBV may rescue RS cel ls from apoptosis,  however,  in EBV negat ive
cases, other transforming events might have taken place. Several oncogenes
and apoptosis regulatory genes were investigated to define which genes are
involved in the rescue of RS cell precursors from apoptosis.
In this thesis,  we studied IP53 and FAS genes in HL. IP53 mutat ions
were ident i f ied in 1 EBV negat ive and 2 EBV posit ive cases out of 26 cHL
cases studied (11,5%), indicat ing that IP53 mutat ions are rare and not
related to EBV status. P53 protein was, however, detected in all HL cases. In
contrast o other malignant umors, p53 protein expression does not correlate
with TP53 mutations in HL. Low frequency of TP53 mutations in HL suggests
involvement of other mechanisms in regulat ion oÍ p53 protein expression in
RS cel ls.
It is known that RS cells from primary HL cases and cell l ines express
FAS protein, however they are insensitive in vitro to FASL mediated
apoptosis.  In humans, germ l ine FAS mutat ions are ident i f ied in more than
B0% of Autoimmune Lymphoprol i ferat ive Syndrome (ALPS) pat ients who
present with var iable phenotypes. These ALPS pat ients have a higher r isk to
develop HL than the normal populat ion. We studied an ALPS pat ient who
presented with a lymph node with pathological  features of ALPS and Nodular
Lymphocyte Predominant HL (NLPHL). Analysis of the FAS gene in this
pat ient indeed revealed a causat ive mutat ion indicat ing that FAS mutat ions
might play a role in conferr ing RS cel l  prebursors resistance to FAS mediated
apoptosis.  In addit ion, we also studied FAS mutat ions in microdissected RS
cel ls of 20 HL cases and 4 HL cel l  l ines. We ident i f ied an intron 7 sol ice si te
mutat ion in L1236 HL cel l  l ine result ing in a truncated FAS protein that lacks
the death domain. A mutat ion in exon 9 with loss of the second al lele was
ident i f ied in one cHL case. Although present,  FAS mutat ions are rare and
only ident i f ied in 2 out of  24 HL (8,3%). The low frequency indicates most
l ikely that other downstream mechanisms in FAS signal ing might be involved
in resistance to FAS induced apoptosis.  lmmunostaining for c-FLIP (FADD-
l ike inter leukin-1B-convert ing enzyme-inhibi tory protein) revealed high
expression in RS cel ls regardless of the histological  subtype. C-FLIP is
known to confer resistance to apoptosis in GC B cel ls.  l t  is possible that c-
FLIP might part ic ipate in conferr ing FAS apoptosis resistance to RS cel ls.
I t  is st i l l  intr iguing how RS cel ls form the react ive background and what is
the nature of interact ions between neoplast ic and inf i l t rat ing cel ls.  We
demonstrated that RS cel ls produce several  chemokines, for example TARC,
t25
MDC, lP-10 and RANTES. TARC is the most specif ic chemokine for cHL,
whereas MDC expression is higher in cHL, but a weaker expression is also
observed in NLPHL and B cel l  NHL. lP-10 and RANTES are higher expressed
in EBV related cHL than in EBV negat ive cHL. Other chemokines are also
expressed in HL (eotaxin, lL-8, SLC, MIP-3cx),  but their  roles in background
formation and their cellular sources are stil l a matter of debate. Overall,
chemokines are higher expressed in HL than in normal t issues, probably
because NF-rB, a transcription factor constitutively activated in RS cells,
regulates expression of many chemokines.
Despite several clinico-pathological differences observed between HL
and non-HL (NHL), i t  was possible to establ ish clonal relat ion between HL and
non-Hl (NHL). We ident i f ied a common precursor cel l  by immunoglobul in
heavy chain gene analyses in a pat ient with Chronic Lymphocyt ic Leukemia
(CLL), which later developed large cel l  lymphoma (LCL) and EBV negat ive
cHL. Our study provided addit ional evidence that c lonal relat ion between EBV
negative composite lymphomas (NHL and cHL) exists.
This thesis demonstrates that genet ic abnormal i t ies in IP53 and FÁS
were ident i f ied only in a minori ty of HL cases and, thus, for the major i ty of HL
cases, the transforming event that rescues RS cell precursors from apoptosis
is st i l l  an open quest ion. By producing several  chemokines, RS cel ls are able
to modulate background formation contributing to escape from host anti tumor
tmmune resoonse.
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